Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLA? 12mm, TiZr, NTP: medical device reports filed with FDA

5,762 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

5,762
device reports naming the brand
0% of all MAUDE reports · about 844 a year
701
reports, 12 months to August 2026
917 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 5,762 reports that name the brand "BL, ? 3.3mm NC, SLA? 12mm, TiZr, NTP" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

701 reports arrived in the 12 months to August 2026, down 24% from 917 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (67.9%), loss of osseointegration (23.9%) and fracture (2.8%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0100199Sep 2021: 63Oct 2021: 35Nov 2021: 68Dec 2021: 412022Jan 2022: 69Feb 2022: 48Mar 2022: 55Apr 2022: 66May 2022: 81Jun 2022: 48Jul 2022: 65Aug 2022: 83Sep 2022: 98Oct 2022: 72Nov 2022: 72Dec 2022: 752023Jan 2023: 123Feb 2023: 63Mar 2023: 62Apr 2023: 62May 2023: 79Jun 2023: 56Jul 2023: 66Aug 2023: 68Sep 2023: 37Oct 2023: 68Nov 2023: 59Dec 2023: 542024Jan 2024: 38Feb 2024: 48Mar 2024: 54Apr 2024: 64May 2024: 65Jun 2024: 59Jul 2024: 57Aug 2024: 81Sep 2024: 54Oct 2024: 130Nov 2024: 115Dec 2024: 692025Jan 2025: 48Feb 2025: 57Mar 2025: 69Apr 2025: 49May 2025: 0Jun 2025: 199Jul 2025: 62Aug 2025: 65Sep 2025: 60Oct 2025: 60Nov 2025: 57Dec 2025: 782026Jan 2026: 69Feb 2026: 58Mar 2026: 59Apr 2026: 58May 2026: 43Jun 2026: 52Jul 2026: 59Aug 2026: 48

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04178342019: 61120192020: 71620202021: 72220212022: 83220222023: 79720232024: 83420242025: 80420252026: 4462026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,762
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report89.3%5,145
Voluntary report0%0
User facility report0%0
Distributor report10.7%617
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,91167.9%62.8%
Loss of osseointegration1,37923.9%22.4%
Fracturea broken bone1622.8%1.6%
Difficult to insertthe device was hard to insert480.8%0.4%
Separation failure90.2%0.1%
Unintended movement70.1%0%
Difficult to removethe device was hard to remove60.1%0%
Defective devicethe device was defective20%0%
Output problem20%0%
Positioning problem20%0.1%
Unstable20%0%
Activation, positioning or separation problem10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,85832.2%
Painpain, site not specified1,22521.3%
Tissue damage81714.2%
Inflammationinflammation4898.5%
Hemorrhage/blood loss/bleeding3716.4%
Swelling/ edema3115.4%
Fistula3105.4%
Abscessa collection of pus2003.5%
Hyperresponsive to stimuli911.6%
Swellingswelling691.2%
Hypersensitivity/allergic reaction540.9%
Failure of implant450.8%
Inadequate osseointegration170.3%
Increased sensitivity150.3%
Numbnessnumbness140.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLA? 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports5,7623,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer89.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLA? 12mm, TiZr, NTP reports

How many FDA reports name BL, ? 3.3mm NC, SLA? 12mm, TiZr, NTP?

5,762 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 701 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (67.9%), loss of osseointegration (23.9%), fracture (2.8%), difficult to insert (0.8%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (89.3%) and distributor reports (10.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLA? 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.